News Channels

18 Sep 2018 GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with advanced or metastatic colorectal cancer
18 Sep 2018 MorphoSys and LEO Pharma Expand Strategic Alliance to Develop Peptide-derived Therapeutics
18 Sep 2018 Neurimmune Achieves Milestone in Collaboration with Ono Pharmaceutical
17 Sep 2018 ITM and Merck KGaA Sign Research Evaluation and Option Agreement to Develop Folate Receptor Targeted Radionuclide Therapy
17 Sep 2018 Oramed Receives FDA Clearance for IND Application for Its Oral GLP-1 Analog Capsule
17 Sep 2018 argenx reports positive topline results from Phase 2 proof-of-concept trial of efgartigimod in primary immune thrombocytopenia
17 Sep 2018 Mersana Announces FDA Lifts Partial Clinical Hold for XMT-1522
17 Sep 2018 Aeglea BioTherapeutics Announces Oral Presentation of Preclinical Data on New Pipeline Therapeutic for Cystinuria at 2018 American Society of Nephrology
17 Sep 2018 CRISPR Therapeutics and ViaCyte Announce Strategic Collaboration to Develop Gene-Edited Stem Cell-Derived Therapy for Diabetes
17 Sep 2018 Eidos Therapeutics Presents Data from its Phase 1 Clinical Trial of AG10 at the 22nd Annual Scientific Meeting of the Heart Failure Society of America
17 Sep 2018 Menlo Therapeutics Begins European Prurigo Nodularis Phase 3 Trial and Presents Additional Data from PN Phase 2 Trial at EADV
17 Sep 2018 Oncolytics Biotech® Announces Investigator Sponsored Multiple Myeloma Study Combining REOLYSIN® and Nivolumab (Opdivo®) with Standard of Care
17 Sep 2018 Inovio Develops Novel H3N2 Influenza DNA Vaccine That Generates Cross-Reactive Responses and Provides Complete Protection Against Lethal Preclinical Challenges
16 Sep 2018 Pfizer Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at the 27th European Academy of Dermatology and Venereology (EADV) Congress
16 Sep 2018 Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults
16 Sep 2018 Kiniksa Presents KPL-716 Clinical Data at the 27th European Academy of Dermatology and Venereology
15 Sep 2018 Positive Phase 3 Results Presented for Dupixent® (dupilumab) Show Significant Improvement on Multiple Measures of Disease Severity in Adolescents with Moderate-to-Severe Atopic Dermatitis
15 Sep 2018 Allergan Announces Results of Higher Dose BOTOX® Cosmetic (onabotulinumtoxinA) for the Treatment of Moderate to Severe Glabellar Lines
15 Sep 2018 Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline
14 Sep 2018 EpimAb Biotherapeutics Announces IND Filing for EMB01 in China and the US

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up